| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0039-128X(96)00242-5 |
| P698 | PubMed publication ID | 9071738 |
| P2093 | author name string | Katzenellenbogen JA | |
| Carlson KE | |||
| Anstead GM | |||
| P2860 | cites work | Sequence and expression of human estrogen receptor complementary DNA | Q24299678 |
| Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model | Q26778456 | ||
| Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid | Q27729334 | ||
| Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha | Q27730245 | ||
| Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol | Q27733290 | ||
| The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors | Q27733398 | ||
| The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
| Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp | Q28271872 | ||
| Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect | Q28292427 | ||
| Impact of Continuously Administered Catechol Estrogens on Uterine Growth and Luteinizing Hormone Secretion* | Q28328299 | ||
| A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. | Q29387463 | ||
| Classical electrostatics in biology and chemistry | Q29615082 | ||
| Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A | Q29619449 | ||
| Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding site | Q30194409 | ||
| Hydrogen bond stereochemistry in protein structure and function | Q30412768 | ||
| Principles of protein-protein recognition | Q33954341 | ||
| Full-length sequence and in vitro expression of rainbow trout estrogen receptor cDNA. | Q34078755 | ||
| The molecular structure of 16 alpha-iodo-17 beta-estradiol, a high affinity ligand for the estrogen receptor | Q34190875 | ||
| Skeletal conformations and receptor binding of some 9,11-modified estradiols | Q72102810 | ||
| Sulfhydryl Groups and Estradiol-Receptor Interaction | Q72318555 | ||
| The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents | Q72322164 | ||
| Comparative binding affinity of estrogens and its relation to estrogenic potency | Q72361449 | ||
| 11 beta-Substituted estradiol derivatives, potential high-affinity carbon-11-labeled probes for the estrogen receptor: a structure-affinity relationship study | Q72538763 | ||
| Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology | Q72550258 | ||
| Synthesis, receptor binding and biodistribution of the gem-21-chloro-21-iodovinylestradiol derivatives | Q72609173 | ||
| Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs | Q72641429 | ||
| 2- and 4-fluorinated 16 alpha(-)[125I]iodoestradiol derivatives: synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake | Q72696577 | ||
| Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex | Q72838502 | ||
| Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives | Q72880568 | ||
| The relationship between estrogenic action and chemical constitution in a group of azomethine derivatives | Q80652311 | ||
| Steroid binding to the cytosolic estrogen receptor from rat uterus. Influence of the orientation of substituents in the 17-position of the 8 beta- and 8 alpha-series | Q93620053 | ||
| Synthesis, receptor binding, and tissue distribution of (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10), 20-tetraene-3,17-diol | Q95584879 | ||
| Steroid structure and function. Molecular conformation of 4-hydroxyestradiol and its relation to other catechol estrogens | Q68374829 | ||
| Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor | Q68419252 | ||
| Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands | Q68560505 | ||
| Estrogen receptor binding characteristics of 1,11 beta-ethanoestradiol: effect of a 1,11 beta-bridge on steroidal estrogen | Q68644953 | ||
| The specificity of the estrogen receptor of human uterus | Q68660894 | ||
| The steroid specificity of the estrogen-receptor of human breast carcinoma | Q68690276 | ||
| Synthesis and structure-affinity of a series of 7 alpha-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers | Q68694310 | ||
| Binding, X-ray and NMR studies of the three A-ring isomers of natural estradiol | Q68718414 | ||
| Photoreactivity of some light-sensitive estrogen derivatives. Use of an exchange assay to determine their photointeraction with the rat uterine estrogen binding protein | Q68776986 | ||
| Synthesis and biologic activities of 11 beta-substituted estradiol as potential antiestrogens | Q68830660 | ||
| Synthesis and biological activity of 4-methylestradiol | Q68835907 | ||
| Quantitative structure-activity relationships of estrogenic steroids substituted at C14, C15 | Q69031639 | ||
| 17 alpha-allyl estradiol analogues as candidates for development of high-affinity fluorescein-estradiol conjugates | Q69496611 | ||
| Quantitation of long-range effects in steroids by molecular orbital calculations | Q69498004 | ||
| The bitter pill | Q69521395 | ||
| 17-Desoxy estrogen analogues | Q69640991 | ||
| Hydrogen bonding and specificity. Fluorodeoxy sugars as probes of hydrogen bonding in the glycogen phosphorylase-glucose complex | Q69685085 | ||
| 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor | Q69703169 | ||
| Evidence for involvement of tyrosine in estradiol binding by rat uterus estrogen receptor | Q70117797 | ||
| Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate | Q70216070 | ||
| Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro | Q70342780 | ||
| The crystal and molecular structures of an unusual estra-steroid and of its dihydroproduct | Q70365984 | ||
| The biologic activity of selenoestrogens | Q70366563 | ||
| Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs | Q70480532 | ||
| Steroidal affinity labels of the estrogen receptor. 1. 17 alpha-(Bromoacetoxy)alkyl/alkynylestradiols | Q70507749 | ||
| Interaction of 17β-estradiol and its specific uterine receptor. Evidence for complex kinetic and equilibrium behavior | Q70639388 | ||
| Steroid structure and function--IX. Molecular conformation and receptor binding of isomeric analogs of D-homo-estradiol | Q70697843 | ||
| A synthesis of 7 alpha-substituted estradiols: synthesis and biological evaluation of a 7 alpha-pentyl-substituted BODIPY fluorescent conjugate and a fluorine-18-labeled 7 alpha-pentylestradiol analog | Q70716658 | ||
| Use of NMR to detect water within nonpolar protein cavities | Q70796495 | ||
| Regio and stereospecific synthesis of 11 beta-substituted 19-norsteroids. Influence of 11 beta-substitution on progesterone receptor affinity - (1) | Q70812012 | ||
| Molecular details of receptor binding and hormonal action of steroids derived from X-ray crystallographic investigations | Q71100503 | ||
| Structure-activity relationships of estrogens. Effects of 14-dehydrogenation and axial methyl groups at C-7, C-9 and C-11 | Q71178028 | ||
| Structure-activity relationships of 9 beta-estrogens | Q71225835 | ||
| Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens | Q71306007 | ||
| 2-hydroxyestradiol-17 alpha and 4-hydroxyestradiol-17 alpha, catechol estrogen analogs with reduced estrogen receptor affinity | Q71317914 | ||
| Synthesis and estrogen receptor binding of (17 alpha, 20E)- and (17 alpha, 20Z)-21-phenylthio- and 21-phenylseleno-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols | Q71454389 | ||
| The androgen receptor binding site: a conformational study of steroids in relation with their affinity--I. Interaction with the D-ring | Q71486380 | ||
| Binding Activity of Oestrogen Receptors destroyed by Iodination | Q71547432 | ||
| The crystal and molecular structure of diethylstilbestrol | Q71565786 | ||
| Studies with steroid-fluorescein conjugates on oestrogen target tissues | Q71642505 | ||
| Benz[a]anthracene diols: predicted carcinogenicity and structure-estrogen receptor binding affinity relationships | Q71769820 | ||
| Substituted derivatives of A-nor-5 alpha-androstane and A-nor-5 alpha-estrane--structure and affinity for hormonal receptors | Q71772386 | ||
| Selenium labeling in nuclear medicine. 2. D ring substituted estrogens | Q71844384 | ||
| 11.beta.-Substituted Estradiol Derivatives. 2. Potential Carbon-11- and Iodine-Labeled Probes for the Estrogen Receptor | Q71943828 | ||
| Molecular modeling of steroidal estrogens: novel conformations and their role in biological activity | Q72102808 | ||
| Hydrogen bonding and biological specificity analysed by protein engineering | Q34192392 | ||
| Functional group contributions to drug-receptor interactions. | Q34245543 | ||
| Radiolabeled steroidal estrogens in cancer research | Q34343021 | ||
| Synthesis of new amino acid and peptide derivatives of estradiol and their binding affinities for the estrogen receptor | Q34360210 | ||
| Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens | Q35035979 | ||
| Structural organization and expression of the mouse estrogen receptor | Q35171830 | ||
| Internal water molecules and H‐bonding in biological macromolecules: A review of structural features with functional implications | Q35222975 | ||
| ICI 182,780, a new antioestrogen with clinical potential | Q35834527 | ||
| Molecular cloning and characterization of rat estrogen receptor cDNA. | Q36122031 | ||
| Correspondence factor analysis of steroid libraries | Q36694765 | ||
| Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid | Q36815924 | ||
| Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding | Q38353979 | ||
| Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors? | Q39484004 | ||
| Computer-aided drug design | Q39767340 | ||
| Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15α,16α,17β-tetrol) | Q39987409 | ||
| Hydrogen bonding in globular proteins | Q40188265 | ||
| Hormonal treatment of postmenopausal women | Q40724769 | ||
| Cysteinyl-tRNA synthetase from Escherichia coli does not need an editing mechanism to reject serine and alanine. High binding energy of small groups in specific molecular interactions | Q41016625 | ||
| Some hypotheses about interactions between estrogen and androgen and their possible receptors | Q41052337 | ||
| Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses | Q41112992 | ||
| Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones | Q41126417 | ||
| Organometallic derivatives of estradiol as bioligands: targetted binding of the estradiol receptor | Q41288685 | ||
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site | Q41335645 | ||
| Flexible Drug Molecules and Dynamic Receptors | Q41346128 | ||
| Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is non-cooperative and has a Kd of approximately 10 pM. | Q41445049 | ||
| 11 beta-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens | Q41456302 | ||
| Estrogen and androgen receptor binding affinity of 10 beta-chloro-estrenen derivatives | Q42210685 | ||
| 11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor | Q42219959 | ||
| 3,17 beta-Dihydroxy-20,21-epoxy-19-norpregna-1,3,5(10)-trienes: synthesis, rearrangement, cytotoxicity, and estrogen-receptor binding | Q42221555 | ||
| Estrogenic steroids. 3. The crystal and molecular structure of estriol | Q42239829 | ||
| Identification of thiol group at the estrogen-binding site on the cytoplasmic receptor from rabbit uterus by affinity labeling | Q42265413 | ||
| The synthesis and study of some potential affinity labeling reagents for estrogen receptors | Q42270748 | ||
| Synthesis and biological activity of some 15-oxaestranes | Q42271799 | ||
| The C-terminal half of the porcine estradiol receptor contains no post-translational modification: determination of the primary structure | Q42595710 | ||
| Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers | Q43680271 | ||
| Segmental motion in catalysis: investigation of a hydrogen bond critical for loop closure in the reaction of triosephosphate isomerase | Q43832154 | ||
| Displacement of Estradiol from Estrogen Receptors by Simple Alkyl Phenols* | Q44037724 | ||
| Solvent effect on binding thermodynamics of biopolymers | Q44089020 | ||
| Docking flexible ligands to macromolecular receptors by molecular shape | Q44113013 | ||
| Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship | Q44314955 | ||
| Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer | Q44983451 | ||
| 17 alpha-substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands | Q45799214 | ||
| A structural role for hormone in the thyroid hormone receptor. | Q46828407 | ||
| Distributions of water around amino acid residues in proteins | Q47643805 | ||
| Photoaffinity labels for estrogen binding proteins of rat uterus | Q47954177 | ||
| DNA recognition by the oestrogen receptor: from solution to the crystal | Q47964761 | ||
| Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart | Q50147052 | ||
| Shielding effects at 17 alpha-substituted estrogens. A tentative explanation for the low biological activity of 17 alpha-ethyl-estradiol based on i.r. and NMR spectroscopic studies | Q50158726 | ||
| Thermodynamic properties of ligand binding by monoclonal anti-fluorescyl antibodies. | Q52630071 | ||
| Internal cavities and buried waters in globular proteins. | Q52638970 | ||
| Kinetics of the hormone-receptor interaction competition experiments with slowly equilibrating ligands | Q52764359 | ||
| The nature of thyroxine and related compounds as electron donors. | Q53803861 | ||
| Steroidal Affinity Labels of the Estrogen Receptor. 2. 17.alpha.-[(Haloacetamido)alkyl]estradiols | Q54170118 | ||
| Steroid flexibility and receptor specificity | Q55867079 | ||
| Receptor Binding as a Tool in the Development of New Bioactive Steroids | Q55868509 | ||
| Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds | Q57975324 | ||
| New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure | Q57975333 | ||
| Properties of a purified estradiol-dependent calf uterus tyrosine kinase | Q58213266 | ||
| Bioorganometallic chemistry: a future direction for transition metal organometallic chemistry? | Q60453442 | ||
| Organometallic estrogens: synthesis, interaction with lamb uterine estrogen receptor, and detection by infrared spectroscopy | Q60453530 | ||
| A canonical structure for the ligand-binding domain of nuclear receptors | Q61818643 | ||
| Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol | Q64936363 | ||
| Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17 alpha, 20E)- and (17 alpha, 20Z)-21-halo-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols. | Q64968852 | ||
| A series of optical structural and isomeric analogs of estradiol: a comparative study of the biological activity and affinity to cytosol receptor of rabbit uterus | Q66839260 | ||
| Seco-oestradiols and some non-steroidal oestrogens: Structural correlates of oestrogenic action | Q66946058 | ||
| The relevance of kinetic parameters in the determination of specific binding to the estrogen receptor | Q67278806 | ||
| Binding characteristics of estrone, estradiol and estriol to the human myometrial estrogen receptor | Q67407512 | ||
| Ligand atom partial charges assignment for complementary electrostatic potentials | Q67508426 | ||
| Post-coital contraceptive activity and estrogen receptor binding affinity of phenolic steroids | Q67541117 | ||
| Interactions of hormonal steroids: progestogens | Q67564481 | ||
| Coumestrol, NBD-norhexestrol, and dansyl-norhexestrol, fluorescent probes of estrogen-binding protiens | Q67593940 | ||
| 11.beta.-Methoxy-, 11.beta.-ethyl, and 17.alpha.-ethynyl-substituted 16.alpha.-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity | Q67677251 | ||
| Contribution of hydrogen bonding to the conformational stability of ribonuclease T1 | Q67731991 | ||
| Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor | Q67940163 | ||
| Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells | Q68000133 | ||
| Estrogen receptor binding tolerance of 16 alpha-substituted estradiol derivatives | Q68060401 | ||
| A model for the determination of the 3D-spatial distribution of the functions of the hormone-binding domain of receptors that bind 3-keto-4-ene steroids | Q68094439 | ||
| Estrogen platinum-diamine complexes: Preparation of a non-steroidal estrogen platinum—diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo | Q68156822 | ||
| A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain | Q68156958 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 268-303 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Steroids | Q15716675 |
| P1476 | title | The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site | |
| P478 | volume | 62 |
| Q73364058 | (17alpha,20E/Z)-iodovinyl- and 16alpha-iodP618-homoestradiol derivatives: synthesis and evaluation for estrogen receptor imaging |
| Q44276605 | 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function |
| Q47902996 | 17beta-estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms |
| Q34510747 | 17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization |
| Q43679872 | 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor |
| Q44430691 | 4-Ethoxymethylphenol: a novel phytoestrogen that acts as an agonist for human estrogen receptors |
| Q28543512 | A click approach to novel D-ring-substituted 16α-triazolylestrone derivatives and characterization of their antiproliferative properties |
| Q49359257 | A computational based approach to identify estrogen receptor alpha/beta heterodimer selective ligands |
| Q35534539 | A new fluorescence complementation biosensor for detection of estrogenic compounds |
| Q45985321 | A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction. |
| Q52546427 | A reactivity pattern for discrimination of ER agonism and antagonism based on 3-D molecular attributes. |
| Q100514335 | A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes |
| Q44263353 | A spin-column procedure for estrogen receptor equilibrium and competition binding analysis |
| Q34132640 | A structural biologist's view of the oestrogen receptor. |
| Q40906788 | AHTN and HHCB show weak estrogenic--but no uterotrophic activity |
| Q34050191 | Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas |
| Q44249252 | Affinity labeling of the nuclear vitamin D receptor with nonsteroidal alkylating agents |
| Q46905071 | Alternative QSAR models for selected estradiol and cytochrome P450 ligands: comparison between classical, spectroscopic, CoMFA and GRID/GOLPE methods |
| Q51566935 | Androgen receptor binding affinity: a QSAR evaluation. |
| Q43902882 | Anti-estrogenic activity of mansonone G and mansorin A derivatives |
| Q89425532 | Aqueous solution interactions with sex hormone-binding globulin and estradiol: a theoretical investigation |
| Q43911168 | Aryl cyclopentadienyl tricarbonyl rhenium complexes: novel ligands for the estrogen receptor with potential use as estrogen radiopharmaceuticals |
| Q43790620 | Assessment of styrene oligomers eluted from polystyrene-made food containers for estrogenic effects in in vitro assays |
| Q36054974 | Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women |
| Q36405734 | Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides. |
| Q46306140 | Binary classification models for endocrine disrupter effects mediated through the estrogen receptor |
| Q58860161 | Binding affinity prediction of novel estrogen receptor ligands using receptor-based 3-D QSAR methods |
| Q39096541 | Bio-Based Aromatic Epoxy Monomers for Thermoset Materials. |
| Q39242672 | Bioactive ergostanoids and a new polyhydroxyoctane from Lentinus polychrous mycelia and their inhibitory effects on E2-enhanced cell proliferation of T47D cells |
| Q93942837 | Biotransformation of the xenoestrogen 4-tert-octylphenol in hepatocytes of rainbow trout (Oncorhynchus mykiss) |
| Q30558181 | Bisphenol A directly targets tubulin to disrupt spindle organization in embryonic and somatic cells |
| Q87478094 | Catalytic asymmetric Torgov cyclization: a concise total synthesis of (+)-estrone |
| Q43750590 | Chemical synthesis of 16beta-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17beta-hydroxysteroid dehydrogenase and binding affinity on steroid receptors. |
| Q36925454 | Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women |
| Q35659606 | Circulating sex steroids and breast cancer risk in premenopausal women |
| Q34006085 | Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens |
| Q44550193 | Comparative effects of long-term continuous release of 16 alpha-hydroxyestrone and 17 beta-estradiol on bone, uterus, and serum cholesterol in ovariectomized adult rats. |
| Q104685776 | Comparative toxicity reduction potential of UV/sodium percarbonate and UV/hydrogen peroxide treatments for bisphenol A in water: An integrated analysis using chemical, computational, biological, and metabolomic approaches |
| Q33804147 | Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-s |
| Q43948886 | Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). |
| Q37054997 | Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration |
| Q28828683 | Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues |
| Q43145367 | Design, synthesis, and evaluation of cyclofenil derivatives for potential SPECT imaging agents |
| Q92156495 | Desymmetrization of cyclic 1,3-diketones via Ir-catalyzed hydrogenation: an efficient approach to cyclic hydroxy ketones with a chiral quaternary carbon |
| Q44246958 | Development and validation of an average mammalian estrogen receptor-based QSAR model |
| Q28482848 | Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions |
| Q34216817 | Development of subtype-selective oestrogen receptor-based therapeutics. |
| Q47309263 | Developmental estrogen exposures and disruptions to maternal behavior and brain: Effects of ethinyl estradiol, a common positive control |
| Q34405638 | Different ligands-different receptor conformations: modeling of the hER alpha LBD in complex with agonists and antagonists |
| Q31857664 | Differential estrogen receptor binding of estrogenic substances: a species comparison |
| Q44760795 | Differential recognition of resveratrol isomers by the human estrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding |
| Q73226598 | Diphenyl quinolines and isoquinolines: synthesis and primary biological evaluation |
| Q33936857 | Directed evolution of specific receptor-ligand pairs for use in the creation of gene switches |
| Q52628626 | Distinct mechanisms of endocrine disruption of DDT-related pesticides toward estrogen receptor α and estrogen-related receptor γ. |
| Q40639094 | Dual action of oestrogens on the mouse constitutive androstane receptor |
| Q33499150 | Dual activities of odorants on olfactory and nuclear hormone receptors |
| Q43521995 | Effects-based chemical category approach for prioritization of low affinity estrogenic chemicals. |
| Q39462062 | Efficient approach to novel 1α-triazolyl-5α-androstane derivatives as potent antiproliferative agents |
| Q77744577 | Estradiol-mimetic probes. Preparation of 17 alpha-(6-aminohexynyl)estradiol biotin, fluorescein and acridinium conjugates |
| Q28239860 | Estrogen and progesterone receptors: from molecular structures to clinical targets |
| Q36631048 | Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women |
| Q31988112 | Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor |
| Q33757725 | Estrogen receptor and the SERM concept |
| Q44070663 | Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor |
| Q34347152 | Estrogen receptor ligands: a patent review update |
| Q24800777 | Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors |
| Q35016384 | Estrogen receptor β ligands: recent advances and biomedical applications. |
| Q38159771 | Estrogen receptors (ERα versus ERβ): friends or foes in human biology? |
| Q34315419 | Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. |
| Q57266234 | Estrogenic Analogues Synthesized by Click Chemistry |
| Q24813818 | Estrogenic activity of styrene oligomers after metabolic activation by rat liver microsomes |
| Q44317859 | Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells |
| Q44284933 | Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes |
| Q44328387 | Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands |
| Q36182602 | Evaluation of activity of an estrogen-derivative as cardioprotector drug using an ischemia-reperfusion injury model |
| Q28533967 | Evaluation of estrogenic potential of flavonoids using a recombinant yeast strain and MCF7/BUS cell proliferation assay |
| Q44230839 | Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, reporter gene assay, and uterotrophic assay |
| Q54115195 | Exchange of bound estrogens and antiestrogens in MCF-7 cells: evidence for ligand-induced stable configurations of the estrogen receptor. |
| Q36848788 | Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer. |
| Q33784228 | Free energies of ligand binding for structurally diverse compounds |
| Q43732259 | Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alpha |
| Q47996526 | Homology model for the ligand-binding domain of the human estrogen receptor |
| Q43844442 | Homology modeling of the estrogen receptor subtype beta (ER-beta) and calculation of ligand binding affinities |
| Q35815534 | Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide. |
| Q61442849 | Identification of Potential Inhibitors from Pyriproxyfen with Insecticidal Activity by Virtual Screening |
| Q73154164 | Identification of novel metabolites of the xenoestrogen 4-tert-octylphenol in primary rat hepatocytes |
| Q24656051 | Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach |
| Q52566240 | In-silico screening using flexible ligand binding pockets: a molecular dynamics-based approach. |
| Q39317381 | Inhibition of serotonin re-uptake by licorice constituents |
| Q24814312 | Interaction of organophosphate pesticides and related compounds with the androgen receptor |
| Q73344026 | Interactions of nitromusk parent compounds and their amino-metabolites with the estrogen receptors of rainbow trout (Oncorhynchus mykiss) and the South African clawed frog (Xenopus laevis) |
| Q35795751 | International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators |
| Q44260466 | Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment |
| Q36452355 | Jostling for position: optimizing linker location in the design of estrogen receptor-targeting PROTACs |
| Q73100830 | Ligand structure influences autologous downregulation of estrogen receptor-alpha messenger RNA |
| Q33796269 | Ligand-binding domain of estrogen receptors |
| Q44369672 | Limited species differences in estrogen receptor alpha-medicated reporter gene transactivation by xenoestrogens |
| Q56619661 | MEDICINAL RADIOPHARMACEUTICAL CHEMISTRY OF METAL RADIOPHARMACEUTICALS |
| Q88879114 | Male lifespan extension with 17-α estradiol is linked to a sex-specific metabolomic response modulated by gonadal hormones in mice |
| Q37245953 | Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens |
| Q77195942 | Methyl hypofluorite in the synthesis of 16-methoxyestradiol stereoisomers |
| Q36427475 | Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds. |
| Q27648855 | Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin |
| Q33747238 | Molecular determinants of tissue selectivity in estrogen receptor modulators |
| Q52603443 | Molecular docking and comparative molecular similarity indices analysis of estrogenicity of polybrominated diphenyl ethers and their analogues. |
| Q47304320 | Molecular docking simulation on the interactions of laccase from Trametes versicolor with nonylphenol and octylphenol isomers |
| Q73034820 | Multidimensional screening and design of pharmaceuticals by using endocrine pharmacophores |
| Q48132418 | Natural Anti-Estrogen Receptor Alpha Antibodies Able to Induce Estrogenic Responses in Breast Cancer Cells: Hypotheses Concerning Their Mechanisms of Action and Emergence |
| Q47312800 | Nonsteroidal estrogen receptor isoform-selective biphenyls |
| Q77195947 | Novel high-affinity steroidal estrogenic ligands: synthesis and receptor binding of 11 beta-vinyl-17 alpha-E/Z-phenylselenovinyl estradiols |
| Q74659510 | Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens |
| Q41007647 | Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation |
| Q53835300 | Oxidation of steroid estrogens by peroxymonosulfate (PMS) and effect of bromide and chloride ions: Kinetics, products, and modeling. |
| Q35758123 | Performance of (consensus) kNN QSAR for predicting estrogenic activity in a large diverse set of organic compounds |
| Q63351930 | Photolysis of estrone generates estrogenic photoproducts with higher activity than the parent compound |
| Q33755530 | Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies. |
| Q24815373 | Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts |
| Q38310858 | Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships |
| Q27637534 | Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor |
| Q34257756 | Probing the Topological Tolerance of Multimeric Protein Interactions: Evaluation of an Estrogen/Synthetic Ligand for FK506 Binding Protein Conjugate |
| Q36164304 | Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α |
| Q51914214 | QSAR and mechanistic interpretation of estrogen receptor binding. |
| Q35135755 | Quantitative comparisons of in vitro assays for estrogenic activities |
| Q34640932 | Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species |
| Q39642498 | Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals |
| Q48092718 | Re-evaluating the Significance of Estrone as an Environmental Estrogen. |
| Q44032798 | Reactivity profiles of ligands of mammalian retinoic acid receptors: a preliminary COREPA analysis |
| Q33997398 | Recent application of analytical methods to phase I and phase II drugs development: a review |
| Q37677204 | Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta |
| Q37438330 | Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women |
| Q43502943 | Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals |
| Q73106218 | Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran |
| Q31120925 | Rigorous 3-dimensional spectral data activity relationship approach modeling strategy for ToxCast estrogen receptor data classification, validation, and feature extraction |
| Q28204373 | SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1 |
| Q36656704 | Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer |
| Q33649621 | Selective estrogen receptor modulators: a look ahead |
| Q34134828 | Selective estrogen receptor modulators: tissue specificity and clinical utility |
| Q73009020 | Specific binding of hydroxylated polychlorinated biphenyl metabolites and other substances to bovine calf uterine estrogen receptor: structure-binding relationships |
| Q43264248 | Stereochemical effects during [M-H]- dissociations of epimeric 11-OH-17beta-estradiols and distant electronic effects of substituents at C(11) position on gas phase acidity. |
| Q35227529 | Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities |
| Q39989999 | Strategic selection of chemicals for testing. Part I. Functionalities and performance of basic selection methods. |
| Q54259305 | Structural requirements of para-alkylphenols to bind to estrogen receptor. |
| Q27667460 | Structure of Estradiol Metal Chelate and Estrogen Receptor Complex: The Basis for Designing a New Class of Selective Estrogen Receptor Modulators |
| Q36243027 | Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists |
| Q44646687 | Structure-Based drug design: synthesis, crystal structure, biological evaluation and docking studies of mono- and bis-benzo[ b ]oxepines as non-steroidal estrogens |
| Q58860169 | Structure-based 3D-QSAR—merging the accuracy of structure-based alignments with the computational efficiency of ligand-based methods |
| Q35867501 | Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds |
| Q43581187 | Substituted benzopyranobenzothiazinones. Synthesis and estrogenic activity on MCF-7 breast carcinoma cells |
| Q39660364 | Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α |
| Q44424791 | Synthesis and Evaluation of B-, C-, and D-Ring-Substituted Estradiol Carboxylic Acid Esters as Locally Active Estrogens |
| Q77740383 | Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium "n + 1" mixed-ligand and thioether-carbonyl complexes |
| Q31512462 | Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives |
| Q78222272 | Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer |
| Q77787994 | Synthesis and evaluation of geldanamycin-estradiol hybrids |
| Q45739405 | Synthesis and receptor-binding examination of 16-hydroxymethyl-3,17-estradiol stereoisomers |
| Q43962539 | Synthesis and receptor-binding examination of 16-hydroxymethyl-3,17-estradiol stereoisomers |
| Q58718708 | Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis |
| Q43966763 | Synthesis of a novel fluorescent probe for estrogen receptor |
| Q40213508 | Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells |
| Q44356885 | Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta |
| Q44653007 | Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives. |
| Q26995692 | Targeting the androgen receptor with steroid conjugates |
| Q43130047 | Tethered indoles as functionalizable ligands for the estrogen receptor |
| Q40647502 | Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs). |
| Q35148605 | The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands |
| Q43715925 | The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid. |
| Q40720904 | The dynamic structure of the estrogen receptor |
| Q45002480 | The effect of tightly bound water molecules on the structural interpretation of ligand-derived pharmacophore models. |
| Q43577969 | The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations. |
| Q40601612 | The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells |
| Q46448864 | The impact of variable selection on the modelling of oestrogenicity |
| Q38003702 | The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy |
| Q40223467 | The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity. |
| Q60951256 | Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules |
| Q36883747 | Thiophene-core estrogen receptor ligands having superagonist activity. |
| Q37727682 | Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor. |
| Q73809933 | Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor |
| Q34067860 | Tunable recognition of the steroid alpha-face by adjacent pi-electron density |
| Q46761300 | Two-step models to predict binding affinity of chemicals to the human estrogen receptor alpha by three-dimensional quantitative structure-activity relationships (3D-QSARs) using receptor-ligand docking simulation |
| Q34347992 | Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands |
| Q31943103 | Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor? |
Search more.